Henry Schein Inc. (NASDAQ:HSIC) Given Consensus Recommendation of “Hold” by Brokerages
Henry Schein Inc. (NASDAQ:HSIC) has received an average rating of “Hold” from the twelve brokerages that are currently covering the firm. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $151.78.
HSIC has been the subject of a number of research reports. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, August 8th. Bank of America Corp. initiated coverage on Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 price objective for the company. Finally, Robert W. Baird reiterated an “outperform” rating and set a $176.00 price objective (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday.
In other news, Director Paul Brons sold 3,381 shares of the company’s stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $164.03, for a total value of $554,585.43. Following the completion of the transaction, the director now owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.27% of the stock is owned by insiders.
Several institutional investors have recently added to or reduced their stakes in the company. Riverhead Capital Management LLC raised its position in Henry Schein by 998.9% in the second quarter. Riverhead Capital Management LLC now owns 453,851 shares of the company’s stock worth $80,241,000 after buying an additional 412,549 shares during the period. UBS Asset Management Americas Inc. raised its position in shares of Henry Schein by 55.7% in the second quarter. UBS Asset Management Americas Inc. now owns 802,401 shares of the company’s stock worth $141,865,000 after buying an additional 286,976 shares during the last quarter. Janus Capital Management LLC raised its position in shares of Henry Schein by 16.5% in the second quarter. Janus Capital Management LLC now owns 2,027,848 shares of the company’s stock worth $358,522,000 after buying an additional 286,929 shares during the last quarter. BlackRock Fund Advisors raised its position in shares of Henry Schein by 11.7% in the first quarter. BlackRock Fund Advisors now owns 2,313,748 shares of the company’s stock worth $399,422,000 after buying an additional 243,031 shares during the last quarter. Finally, Virginia Retirement Systems ET AL purchased a new position in shares of Henry Schein during the second quarter worth approximately $32,832,000. 91.98% of the stock is owned by hedge funds and other institutional investors.
Shares of Henry Schein (NASDAQ:HSIC) traded up 0.66% during mid-day trading on Thursday, hitting $162.40. The stock had a trading volume of 174,973 shares. The company has a market cap of $13.28 billion, a PE ratio of 27.51 and a beta of 1.05. The stock’s 50-day moving average is $162.55 and its 200 day moving average is $170.55. Henry Schein has a 12 month low of $137.70 and a 12 month high of $183.00.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.63 by $0.01. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.85 billion. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The company’s quarterly revenue was up 9.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.46 earnings per share. On average, equities research analysts forecast that Henry Schein will post $6.57 earnings per share for the current fiscal year.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.